RxDoctor Payments Data

Jeffrey Schwimmer

Pediatric Gastroenterology · San Diego, CANPI 1932270782

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,539 of the $4,060 with a category attached, or 62.5%. 3 manufacturers reported payments, led by Merck at 43.6% of the total.

$4,060in general payments, 2019–2025

Across 6 payments — averaging $676.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2K
  • Madrigal Pharmaceuticals$2K
  • Novo Nordisk AS$770
$998,944in research payments, 2019–2025

Across 16 payments — averaging $62,434 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$999K

What the payments were for

  • Consulting fees$2,53963%
  • Speaking & faculty fees$1,41035%
  • Travel & lodging$361%
  • Food & beverage$762%

General payments by program year

19
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck2$1,769
Madrigal Pharmaceuticals3$1,522
Novo Nordisk AS1$770

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,060 in reported general payments places this provider in the 80th percentile of 220 pediatric gastroenterology providers in California.

See all pediatric gastroenterology providers in California →

Other pediatric gastroenterology in San Diego

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →